Moonlake Immunotherapeutics Share Price (NASDAQ: MLTX)
$55.96
▲
1.79
(3.3%)
Last updated on
Check the interactive Moonlake Immunotherapeutics Stock chart to analyse performance
Moonlake Immunotherapeutics stock performance
as on August 23, 2025 at 1:29 AM IST
- Today's Low:$54.21Today's High:$56.13
3.13%
Downside
Day's Volatility :3.42%
Upside
0.3%
- 52 Weeks Low:$31.4252 Weeks High:$58.26
43.85%
Downside
52 Weeks Volatility :46.07%
Upside
3.95%
Moonlake Immunotherapeutics Stock Returns
Moonlake Immunotherapeutics Key Stats
Check Moonlake Immunotherapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Moonlake Immunotherapeutics Stock including INR - Dollar returns
The Moonlake Immunotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Moonlake Immunotherapeutics investment value today
Current value as on today
₹1,16,753
Returns
₹16,753
(+16.75%)
Returns from Moonlake Immunotherapeutics Stock
₹12,437 (+12.44%)
Dollar Returns*
₹4,316 (+4.32%)
Indian investors sentiment towards Moonlake Immunotherapeutics Stock
Global Institutional Holdings in Moonlake Immunotherapeutics
Name
Holdings %
Bvf Inc
31.12%
Cormorant Asset Management, LLC
13.38%
FMR Inc
9.97%
venBio Select Advisor LLC
6.54%
T. Rowe Price Associates, Inc.
4.12%
Citadel Advisors Llc
2.33%
Analyst Recommendation on Moonlake Immunotherapeutics Stock
Buy
81%Buy
18%Hold
0%Sell
Based on 22 Wall street analysts offering stock ratings for Moonlake Immunotherapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Moonlake Immunotherapeutics Share Price Target
What analysts predicted
Upside of 39.13%
Target:
$77.86
Current:
$55.96
Moonlake Immunotherapeutics share price target is $77.86, a slight Upside of 39.13% compared to current price of $55.96 as per analysts' prediction.
Moonlake Immunotherapeutics Stock Insights
Price Movement
In the last 3 years, MLTX stock has moved up by 499.7%MLTX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 71.2% return, outperforming this stock by 62.8%
Moonlake Immunotherapeutics Technicals Summary
Sell
Neutral
Buy
Moonlake Immunotherapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Moonlake Immunotherapeutics Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 1.65% | 36.57% | 12.4% | 520.87% | 356.65% |
 | 5.93% | -17.37% | -50.85% | -2.23% | -0.91% |
 | 5.81% | 21.35% | 61.84% | 78.01% | 32.14% |
 | -15.86% | -17.97% | -17.9% | 35.76% | 47.74% |
 | 42.31% | 82.49% | 66.63% | 105.56% | 244.81% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -3.36 | -0.4 | -0.25 | NA | 5.57 |
| 15.08 | 15.08 | 1.23 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.29 | -0.05 | -0.01 | NA | 34.32 |
| 28.25 | 28.25 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $3.4B | 356.65% | NA | 0.0% |
| Buy | $63.4B | -0.91% | 15.08 | 31.37% |
| NA | $38.2B | 32.14% | NA | -3.89% |
| Buy | $101.9B | 47.74% | 28.25 | 31.86% |
| Buy | $60.1B | 244.81% | NA | -12.96% |
Moonlake Immunotherapeutics Dividend announcements
Moonlake Immunotherapeutics Earnings
Moonlake Immunotherapeutics’s price-to-earnings ratio stands at None
About Moonlake Immunotherapeutics
Key Management of Moonlake Immunotherapeutics
Important FAQs about investing in MLTX Stock from India :
What is Moonlake Immunotherapeutics share price today?
Moonlake Immunotherapeutics share price today is $55.96 as on at the close of the market. Moonlake Immunotherapeutics share today touched a day high of $56.13 and a low of $54.21.
What is the 52 week high and 52 week low for Moonlake Immunotherapeutics share?
Moonlake Immunotherapeutics share touched a 52 week high of $58.26 and a 52 week low of $31.42. Moonlake Immunotherapeutics stock price today i.e. is closed at $55.96, lower by 3.95% versus the 52 week high.
How to invest in Moonlake Immunotherapeutics Stock (MLTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Moonlake Immunotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Moonlake Immunotherapeutics Shares that will get you 0.0268 shares as per Moonlake Immunotherapeutics share price of $55.96 per share as on August 23, 2025 at 1:29 AM IST.
What is the minimum amount required to buy Moonlake Immunotherapeutics Stock (MLTX) from India?
Indian investors can start investing in Moonlake Immunotherapeutics (MLTX) shares with as little as ₹87.521 or $1 (as of August 23, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Moonlake Immunotherapeutics stock (as per the Rupee-Dollar exchange rate as on August 23, 2025).
Based on Moonlake Immunotherapeutics share’s latest price of $55.96 as on August 23, 2025 at 1:29 AM IST, you will get 0.1787 shares of Moonlake Immunotherapeutics. Learn more about
fractional shares .
What are the returns that Moonlake Immunotherapeutics has given to Indian investors in the last 5 years?
Moonlake Immunotherapeutics stock has given 356.65% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?
Discover More
Six Flags Entertainment Corp$26.07
+1.88%
S&p Biotech Spdr Etf$90.92
+1.11%
Janus Henderson Mortgage-backed Securities Etf$45.13
+0.58%
- Avantis International Small Cap Value Etf
$86.20
+2.11%
Fidelity Msci Health Care Etf$66.05
+0.99%
Phina Inc.$58.28
+3.46%
- Waystar Holding Corp.
$36.23
+1.34%
